weight loss drug news today glp-1 september 2025 Patients taking an experimental oral lost significant and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other Eli Lilly to seek approval

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) show substantial efficacy in regulating blood glucose levels and lipid metabolism, initially as an effective treatment for diabetes mellitus

To date, the GLP-1 Supply Tracker has generated more than 50,000 crowdsourced shortage reports and thousands of supply reports, data which Ro has shared with the FDA

Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor

doi: 10.1152/ajpgi.1998.275.5.G984 81 LeePJPapachristouGI

Its safe for use with medications, including those for type 2 diabetes, and does not contain common allergens like gluten, caffeine, or GMOs

Then a landmark clinical trial enrolled thousands of patients with high-risk breast cancer, gave them either metformin or a placebo alongside standard treatment, and followed them for five years